Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Neuroprotection trial design in progressive supranuclear palsy: challenges and solutions
Saved in:
| Published in: | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Neuroprotection trial design in progressive supranuclear palsy: challenges and solutions
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- The utility of a composite endpoint for tracking disease progression in Lewy body dementia
- Automated analysis of expressive prosody in Dutch patients with behavioral variant frontotemporal dementia and primary progressive aphasia
- Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials
- From clinical trial to clinical experience: Lecanemab therapy in a real‐world case series
- A Scoping Review on the Attributes of Cluster Randomized Controlled Trials in Long-Term Care Facilities